Cue Biopharma Ownership | Who Owns Cue Biopharma?

Overview Forecast RevenueFinancials Chart

Cue Biopharma Ownership Summary

Cue Biopharma is owned by 18.92% institutional investors, 0.34% insiders, and 80.75% retail investors. Bleichroeder lp is the largest institutional shareholder, holding 7.14% of CUE shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.18% of its assets in Cue Biopharma shares.

CUE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cue Biopharma	18.92%	0.34%	80.75%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bleichroeder lp	6.82M	7.14%	$4.90M
Catalytic wealth ria	3.43M	3.59%	$2.47M
Vanguard group	3.04M	3.18%	$2.19M
Blackrock	756.74K	1.53%	$938.35K
Geode capital management	800.77K	0.84%	$575.60K
Boothbay fund management	610.96K	0.64%	$439.10K
Robertson stephens wealth management	478.50K	0.50%	$343.90K
Bank of america corp /de/	242.57K	0.49%	$300.78K
Blackrock funding, inc. /de	449.16K	0.47%	$322.81K
Advisory research	257.23K	0.27%	$184.87K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bleichroeder lp	6.82M	0.96%	$4.90M
Catalytic wealth ria	3.43M	0.08%	$2.47M
Advisory research	257.23K	0.02%	$184.87K
Robertson stephens wealth management	478.50K	0.01%	$343.90K
Boothbay fund management	610.96K	0.01%	$439.10K
Angeles wealth management	120.00K	0.01%	$86.24K
Navalign	25.00K	0.00%	$17.97M
Two sigma securities	39.51K	0.00%	$28.40K
Prevail innovative wealth advisors	18.99K	0.00%	$13.65K
Texas capital bank wealth management services	33.10K	0.00%	$23.79K

Top Buyers

Holder	Shares	% Assets	Change
Boothbay fund management	610.96K	0.01%	610.96K
Geode capital management	800.77K	-	108.59K
Catalytic wealth ria	3.43M	0.08%	100.00K
Renaissance	227.06K	0.00%	93.60K
Squarepoint ops	85.80K	0.00%	85.80K

Top Sellers

Holder	Shares	% Assets	Change
Slate path capital lp	-	-	-2.40M
Blackrock	756.74K	-	-1.49M
Good life advisors	-	-	-400.00K
Monaco asset management sam	-	-	-253.19K
Y-intercept (hong kong)	-	-	-153.63K

New Positions

Holder	Shares	% Assets	Change	Value
Boothbay fund management	610.96K	0.01%	610.96K	$439.10K
Macquarie group	1.80K	-	1.80K	$2.24K
Citigroup	132.00	-	132.00	$95.00
Sbi securities	1.00	-	1.00	$1.00

Sold Out

Holder	Change
Assetmark	-2.00
Nelson, van denburg & campbell wealth management group	-7.00
Farther finance advisors	-43.00
Innealta capital	-49.00
Point72 (difc)	-66.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	49	8.89%	18,058,423	4.34%	18	5.75%	14	-17.65%	13	44.44%
Jun 30, 2025	46	-9.80%	17,348,745	52.15%	18	7.71%	18	12.50%	9	-30.77%
Mar 31, 2025	51	-10.53%	11,402,706	-3.03%	15	2.91%	16	-48.39%	13	116.67%
Dec 31, 2024	55	5.77%	11,733,877	-15.65%	22	3.11%	30	150.00%	6	-64.71%
Sep 30, 2024	51	-32.00%	13,910,291	0.71%	27	3.48%	13	-61.76%	17	-15.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.35M	2.18%	-1.00
Vanguard Total Stock Mkt Idx Inv	1.53M	2.00%	-33.38K
Vanguard Institutional Extnd Mkt Idx Tr	973.98K	1.27%	-614.71K
Fidelity Extended Market Index	395.19K	0.51%	48.42K
Fidelity Total Market Index	140.86K	0.18%	32.28K
NT R2000 Growth Index Fund - NL	103.76K	0.17%	-
BlackRock Extended Equity Market K	103.23K	0.17%	-44.00
NT R2000 Index Fund - NL	89.94K	0.15%	-9.65K
Fidelity Series Total Market Index	106.35K	0.14%	17.31K
Extended Equity Market Fund K	100.14K	0.13%	-2.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 16, 2024	PASSERI DANIEL R	CHIEF EXECUTIVE OFFICER	Buy	$30.90K
Aug 25, 2023	Suri Anish	PRESIDENT AND CSO	Buy	$11.04K
Aug 14, 2023	PASSERI DANIEL R	CHIEF EXECUTIVE OFFICER	Buy	$8.58K
Mar 23, 2023	Kiener Peter A	-	Sell	$30.59K
May 27, 2022	Morich Frank		Buy	$105.00K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	1	-

CUE Ownership FAQ

Who Owns Cue Biopharma?

Cue Biopharma shareholders are primarily institutional investors at 18.92%, followed by 0.34% insiders and 80.74% retail investors. The average institutional ownership in Cue Biopharma's industry, Biotech Stocks , is 45.22%, which Cue Biopharma falls below.

Who owns the most shares of Cue Biopharma?

Cue Biopharma’s largest shareholders are Bleichroeder lp (6.82M shares, 7.14%), Catalytic wealth ria (3.43M shares, 3.59%), and Vanguard group (3.04M shares, 3.18%). Together, they hold 13.92% of Cue Biopharma’s total shares outstanding.

Does Blackrock own Cue Biopharma?

Yes, BlackRock owns 1.53% of Cue Biopharma, totaling 756.74K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 938.35K$. In the last quarter, BlackRock decreased its holdings by -1.487M shares, a -66.28% change.

Who is Cue Biopharma’s biggest shareholder by percentage of total assets invested?

Bleichroeder lp is Cue Biopharma’s biggest shareholder by percentage of total assets invested, with 0.96% of its assets in 6.82M Cue Biopharma shares, valued at 4.9M$.

Who is the top mutual fund holder of Cue Biopharma shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cue Biopharma shares, with 2.18% of its total shares outstanding invested in 1.35M Cue Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools